Global Endoluminal Suturing Devices Market Is Likely to Grow at A CAGR Value of Around 11.80% By 2028

The global endoluminal suturing devices market was worth around USD 45.10 million in 2021 and is estimated to grow to about USD 88.06 million by 2028, with a compound annual growth rate (CAGR) of approximately 11.80 percent over the forecast period. The report analyzes the endoluminal suturing devices market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the endoluminal suturing devices market.

The rising obesity rate and chronic diseases that contribute to patient pools, as well as the emerging trend for minimally invasive operations, are the significant factors driving the global endoluminal suturing devices market expansion. Endoluminal surgeries are becoming more popular as people become more aware of the benefits of minimally invasive procedures and the reduction in post-surgical problems. The majority of endoluminal suturing devices are used in hospitals due to the vast number of patients undergoing gastrointestinal treatments in hospitals. As a result, the incorporation of robotics in endoluminal suturing devices would increase market growth. The widespread availability of gastrointestinal diseases is due to the adoption of an unhealthy lifestyles, as well as an unhealthy diet and alcohol misuse, which will fuel market expansion.

Endoluminal suturing devices are applied in a variety of treatments, including bariatric surgery, gastroesophageal reflux disease, and gastrointestinal problems. Growing consumer preference for minimally invasive surgical treatments is also expected to drive the global endoluminal suturing devices market forward in the approaching years. For raising the revenue from the emerging market manufacturers are actively focusing on various tactics such as mergers & acquisitions, partnerships, and new product releases. However, the rising cost of procedures is a restricting factor for the market over the upcoming years. Technological advances and the presence of significant industry competitors are likely to drive the market growth.

The global endoluminal suturing devices market is segregated based on applications, end-use, and region. Based on applications, the market is divided into bariatric surgery, gastrointestinal surgery, gastroesophageal reflux disease surgery. Among these the gastrointestinal segment dominates the market. Based on end user, market is segregated into hospitals, ambulatory surgical centers. The hospitals segment dominates the market over the upcoming years.

North America dominates the global endoluminal suturing devices market during the forecast period due to favorable reimbursement policies. The presence of a significant patient population for surgery, as well as rising economies and increased medical tourism are also propelling the market growth over the upcoming years. Furthermore, moderately active lifestyles are also expected to boost the market growth during the forecast period. Over the forecast period, the Asia Pacific regional market is expected to be the fastest-growing regional market due to government guidelines and increasing population. Also, due to the rise of various chronic and infectious diseases in developing nations such as India and China are expressing exponential growth during the forecast period.

Additionally, changes in environment as well as the growing urbanization and changing lifestyle, facilitate the spread of gastrointestinal disorders in the region. Furthermore, industrialized countries such as India and China are dealing with many health conditions and infectious ailments, require minimally invasive surgery.

Key players functioning in the global endoluminal suturing devices mar kept include kept include Apollo Endo-surgery, Inc.; Ethicon Endo-Surgery (Johnson and Johnson); Medtronic Plc.

Recent developments:

• In December 2020, Apollo Endo-surgery, Inc. announced the sale of its surgical product line laparoscopic bariatric surgery to Reshape Lifesciences. This will boost Apollo's Endo-bariatric product offerings.
• June 2021, Ethicon, a Johnson & Johnson subsidiary, and a leading company in flexible endoluminal robotics and soft tissue microwave ablation, announced that the new medical technologies guidelines issued by the National Institute for Health and Care Excellence (NICE) had recommended the use of its Plus Sutures.

Browse the full “Endoluminal Suturing Devices Market Type (Bariatric Surgery, Gastrointestinal Surgery, Gastroesophageal Reflux Disease Surgery), By End-Use (Hospitals, Ambulatory Surgical Centers) and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/endoluminal-suturing-devices-market

Global endoluminal suturing devices market is segmented as follows:

By Type

• Bariatric Surgery
• Gastrointestinal Surgery
• Gastroesophageal Reflux Disease Surgery
• Others

By End-Use Outlook

• Hospitals
• Ambulatory Surgical Centers
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com